Botanical species · safety record

Moringa aptera

The EFSA Compendium of Botanicals holds 6 constituent measurements and 2 adverse-effect records for Moringa aptera. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Moringa aptera Gaertn.

6Constituent measurements

2Safety records

4Cited sources

0Licensed products (Canada)

Also recorded as

Hyperanthera peregrina Forssk.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Phytic acid	Seed	—	26 Milligram/gram	Colorimetry, Spectroscopy (Spectrometry) and Photometry	Resolve DOI
Saponins	Fruit unspecified	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	Resolve DOI
Alkaloids	Leaves	Drying (dehydration)	—	GC-MS	No resolvable identifier
Cardiac glycosides	Leaves	Drying (dehydration)	—	GC-MS	No resolvable identifier
Glucosinolates	Leaves	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Tannins	Leaves	Drying (dehydration)	—	GC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Seed	—	—	In vitro	Resolve DOI
Digestive	Digestive: pancreas	Seed	—	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

ALKAHTANI, HA. SOME ANTINUTRITIONAL FACTORS IN MORINGA-PEREGRINA (AL-YASSAR OR AL-BAN) AND SOYBEAN PRODUCTS . Journal of food science, 1995, vol. 60, no. 2, p. 395-398. DOI
Al-Owaisi, Mooza., Al-Hadiwi, Nora., Khan, Shah Alam. GC-MS analysis, determination of total phenolics, flavonoid content and free radical scavenging activities of various crude extracts of Moringa peregrina (Forssk.) Fiori leaves . Asian pacific journal of tropical biomedicine, 2014, vol. 4, no. 12, p. 964-970.
Abu-Hamdah, S., Afifi, FU., Shehadeh, M., Khalid, S. Simple quality-control procedures for selected medicinal plants commonly used in Jordan . Pharmaceutical biology, 2005, vol. 43, no. 1, p. 1-7. DOI
Bellostas, N., S�rensen, J.C., Nikiema, A., S�rensen, H., Pasternak, D., Kumar, S. Glucosinolates in leaves of moringa species grown and disseminated in Niger. African Journal of Agricultural Research, 2010, vol. 5, no. 11, p. 1338-1340.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature